Document is current
Any future updates will be listed below
-
Authors
Hofman, Delian E.
Magrì, Tonia
Moor, Catharina C.
Richeldi, Luca
Wijsenbeek, Marlies S.
Waseda, Yuko
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 1 October 2024
First Online: 1 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: D.E.H. is paid a salary by the Netherlands Organisation for Health Research and Development. T.M. declares no competing interests. C.C.M.: Grants and fees from Boehringer-Ingelheim and Astra-Zeneca-Daiichi Sankyo paid to institution. L.R.: Grants and fees from Boehringer Ingelheim, Zambon, Roche, FibroGen, Nitto, Pliant Therapeutics, BMS, and CSL Behring. M.S.W.: Grants and fees from The Netherlands Organisation for Health Research and Development, The Dutch Lung Foundation, The Dutch Pulmonary Fibrosis organization, Sarcoidosis.nl, Boehringer Ingelheim, Hoffman la Roche, AstraZeneca-Daiichi, Bristol Myers Squibb, Galapagos, Alecto, GSK, Horizon therapeutics, Kinevant sciences, Molecure, Nerre Therapeutics, Novartis, PureTech Health, Thyron, Trevi, Vicore, and CSL Behring paid to institution. Y.W.: Grants and fees from Boehringer Ingelheim, Nippon Boehringer Ingelheim, Chugai, Taiho, Thermofisher Diagnostics, Glaxo SmithKline, Kyorin, Astra Zeneca, Sanofi, Nippon Shinyaku, and Novo Nordisk.
